- Home
- MPX vs FULC Comparison
MPX vs FULC Comparison
Compare MPX & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- FULC
- Stock Information
- Founded
- MPX 1965
- FULC 2015
- Country
- MPX United States
- FULC United States
- Employees
- MPX N/A
- FULC N/A
- Industry
- MPX Marine Transportation
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- MPX Industrials
- FULC Health Care
- Exchange
- MPX Nasdaq
- FULC Nasdaq
- Market Cap
- MPX 312.9M
- FULC 372.2M
- IPO Year
- MPX N/A
- FULC 2019
- Fundamental
- Price
- MPX $9.27
- FULC $7.47
- Analyst Decision
- MPX
- FULC Buy
- Analyst Count
- MPX 0
- FULC 8
- Target Price
- MPX N/A
- FULC $7.13
- AVG Volume (30 Days)
- MPX 18.6K
- FULC 411.3K
- Earning Date
- MPX 10-23-2025
- FULC 07-29-2025
- Dividend Yield
- MPX 6.16%
- FULC N/A
- EPS Growth
- MPX N/A
- FULC N/A
- EPS
- MPX 0.40
- FULC N/A
- Revenue
- MPX $224,368,000.00
- FULC N/A
- Revenue This Year
- MPX $3.97
- FULC N/A
- Revenue Next Year
- MPX $13.02
- FULC N/A
- P/E Ratio
- MPX $22.73
- FULC N/A
- Revenue Growth
- MPX N/A
- FULC 2752.05
- 52 Week Low
- MPX $7.49
- FULC $2.32
- 52 Week High
- MPX $10.32
- FULC $9.30
- Technical
- Relative Strength Index (RSI)
- MPX 60.71
- FULC 60.45
- Support Level
- MPX $8.74
- FULC $6.35
- Resistance Level
- MPX $9.12
- FULC $7.87
- Average True Range (ATR)
- MPX 0.29
- FULC 0.37
- MACD
- MPX 0.03
- FULC 0.12
- Stochastic Oscillator
- MPX 100.00
- FULC 73.03
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.